0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Artificially Induced Pulmonary Embolism in Dogs

CHARLES B. WITT JR., M.D.
Arch Surg. 1962;84(6):665-669. doi:10.1001/archsurg.1962.01300240069010.
Text Size: A A A
Published online

The earliest effective approach to thromboembolic disease made use of heparin and the coumarin drugs. Ideally, these agents should dissolve an existing thrombus, but their only therapeutic action lies in preventing an extension or embolization of the thrombus.1 Their role in the actual prevention of recurrent thrombosis is subject to question in many series because of the lack of control clinical material. Much evidence is based on subjective findings, rather than objective data. None of the anticoagulant drugs satisfy the process of complete clot dissolution in vivo.2-4 After several weeks the body may partially overcome the tissue damage, and recanalization may occur after injury.

With the realization that fibrin is the primary constituent of intravascular thrombi, and with the discovery of an intrinsic fibrinolytic system in plasma5 (which in the dog is more active than in the human), investigation surged forward to find the ideal agent.

Probably

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();